S17-337A HIV Latency Reversal Agents that target Chromatin remodeler-driven repressive HIV promoter structure Disease indication - HIV infection, specifically reversal of viral latency alone or in combination with other latency reversal agents to improve reservoir targeting. Gerald Crabtree Emily Dykhuizen Tokameh Mahmoudi